EBK PHARMACOLOGY AND THE NURSING PROCES
EBK PHARMACOLOGY AND THE NURSING PROCES
8th Edition
ISBN: 9780323358989
Author: Snyder
Publisher: Elsevier Course Content Deliv.
Question
Book Icon
Chapter 48, Problem 1O
Summary Introduction

To discuss:

The role immunosuppressive therapy in organ transplantation and in the treatment of autoimmune disease.

Concept introduction:

The main role of antibodies in the body is to provide protection against invading pathogens, in some case the antibodies act against the body and cause auto-immune disorders. The antibodies also act against different types of major histocompatibility complex during an organ transplant.

Expert Solution & Answer
Check Mark

Explanation of Solution

The immunosuppressive therapy is administered to suppress the immune system. The immunosuppressive therapy is given during the organ transplant and also used to treat autoimmune disorders. During the organ transplantation, the donor and recipient are matched by the histocompatibility complex, unlike for closest relatives the MHC of others will not match with the recipient and result in the organ rejection. Even if the organ is transplanted from the closest relatives, sometimes the antibodies can recognize the donor’s organ as foreign and that result in rejection. To avoid these complexes, the immunosuppressant drugs are helpful to suppress the activity of the donor’s antibodies and make them think the donor’s organ as self. While in the case of autoimmune disease, the antibodies attack the self-host system results in autoimmune disorders. The anti-antibody is suppressed by the immunosuppressant drugs.

Conclusion

The immunosuppressant drugs are given to reduce the potential activity of the auto-antibodies in autoimmune disorders as well as to suppress the antibodies that are produced against foreign MHC during an organ transplant.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!
Students have asked these similar questions
DaVita Dietitian Reference Manual Module 7- Adequacy of Hemodialysis CASE STUDIES Case 1 David was diagnosed with chronic kidney disease a year ago, and now needs hemodialysis. At his first treatment, the nurse hooks up the bloodlines to an access in David's chest. He tells her that he had surgery on his arm three months ago so it can be used for dialysis eventually. 1. What type of access does David have for the initial treatment? 2. Is David's arm access most likely a graft or fistula? 3. What possible reasons prevent use of a fistula or graft for the first dialysis treatment? Case 2 Ramon, a hemodialysis patient for six years, has lost 1.5 kg over the past six weeks. He denies nausea or vomiting, but does admit to eating less at meals and skipping dinner some days. Current dialysis prescription is: 3 1/2 hours (210 minutes), 3 times a week, ASAHI 1050S, APS dialyzer, dialysis flow rate 800 ml/min, blood flow rate 400 ml/min. Monthly bloodwork is as follows: Date K PO4 Pre-BUN…
DaVita Dietitian Reference Manual Module 7 - Adequacy of Hemodialysis REVIEW QUESTIONS True False 1. 27 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. Urea Reduction Ratio is a more accurate measurement of dialysis adequacy than Urea Kinetic Modeling. A fistula is the preferred type of vascular access. In the formula Kt/V, the V represents volume of total body water in which urea is distributed. In the formula Kt/V, time is measured in 15-minute increments, so 220 minutes would be rounded off to the nearest quarter hour. The DaVita minimum goal for adequacy is a spKt/V≥ 1.0. A measured height and accurate dry weight are required to obtain an accurate Kt/V result. A very low post BUN result usually means the patient is not eating enough protein. KRU is a measure of residual urea clearance by the patient's kidney, requiring a 24-hour urine collection. The Kt/V Delivered (single pool) is the value used for determining adequacy and comparing outcomes in DaVita facilities. Catheters are…
DaVita Dietitian Reference Manual Module 7 - Adequacy of Hemodialysis Case 3 Beverly's monthly adequacy of dialysis results came back lower than usual. Her Kt/V is 1.13. Flow sheet data reveals the following: Prescribed BFR 400, patient ran BFR 325 during treatment Blood pressure dropped to 72/58 during treatment, so UFR was turned off. Dry weight 65 kg, pre dialysis weight 69 kg, post dialysis weight 66.5 kg 1. What are DaVita's goals for Kt/V? 2. What is your impression of why the Kt/V is low? 3. What additional information would help in determining why Beverly's adequacy results were below goal?
Knowledge Booster
Background pattern image
Similar questions
SEE MORE QUESTIONS
Recommended textbooks for you
Text book image
Phlebotomy Essentials
Nursing
ISBN:9781451194524
Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)
Publisher:JONES+BARTLETT PUBLISHERS, INC.
Text book image
Gould's Pathophysiology for the Health Profession...
Nursing
ISBN:9780323414425
Author:Robert J Hubert BS
Publisher:Saunders
Text book image
Fundamentals Of Nursing
Nursing
ISBN:9781496362179
Author:Taylor, Carol (carol R.), LYNN, Pamela (pamela Barbara), Bartlett, Jennifer L.
Publisher:Wolters Kluwer,
Text book image
Fundamentals of Nursing, 9e
Nursing
ISBN:9780323327404
Author:Patricia A. Potter RN MSN PhD FAAN, Anne Griffin Perry RN EdD FAAN, Patricia Stockert RN BSN MS PhD, Amy Hall RN BSN MS PhD CNE
Publisher:Elsevier Science
Text book image
Study Guide for Gould's Pathophysiology for the H...
Nursing
ISBN:9780323414142
Author:Hubert BS, Robert J; VanMeter PhD, Karin C.
Publisher:Saunders
Text book image
Issues and Ethics in the Helping Professions (Min...
Nursing
ISBN:9781337406291
Author:Gerald Corey, Marianne Schneider Corey, Cindy Corey
Publisher:Cengage Learning